Video Library
Drugs Used to Treat Thromboembolic Disorders > Pharmacology
Exam Review
Comprehensive Questions
Total Questions : 20
Showing 20 questions, Sign in for moreA patient recently developed palpitations and went to see a healthcare provider who diagnosed atrial fibrillation. The patient was then started on an antiarrhythmic and an anticoagulant. The nurse recognizes which of the following conditions are reasons for having patients receive anticoagulant therapy? Select all that apply
The nurse reviewed the mechanism of action for those medications that are used for patients with blood clots or for those at risk for developing blood clots. Indicate with an ‘X’ the effect each drug classification will have.
Explanation
Pathological thrombus formation triggers ischemic injury, necessitating targeted pharmacological therapies to maintain vascular patency. Antithrombotics modulate the coagulation cascade, while fibrinolytics actively degrade fibrin matrices to restore perfusion. These agents carry significant risk of hemorrhage, requiring precise monitoring of bleeding parameters.
Rationale for correct answers:
Fibrinolytic agents like alteplase catalyze the conversion of plasminogen to plasmin. Plasmin directly cleaves fibrin polymers, which effectively dissolves clots that have already formed in the vasculature. This action restores immediate perfusion to ischemic tissues during acute myocardial infarction or ischemic stroke.
Thrombus formation is prevented prophylactically by platelet inhibitors, thrombin inhibitors, and anticoagulants. These agents disrupt early chemical cascades or cellular adhesion pathways to stop new clot propagation. Inhibiting these pathways ensures that pathological coagulation is suppressed in high-risk patients.
Platelet inhibitors like aspirin block cyclooxygenase-1 or adenosine diphosphate receptors on cellular membranes. This disruption directly halts activation signals and prevents platelet aggregation at sites of vascular endothelial injury. Consequently, the primary platelet plug cannot form to initiate a clot.
Anticoagulants and thrombin inhibitors stop the secondary coagulation cascade to arrest clot growth. By neutralizing clotting factors like thrombin or factor Xa, they halt further fibrin deposition on established clots. This prevents the dangerous extension of an existing deep vein thrombus.
Rationale for incorrect answers:
None of these therapeutic drug classifications decrease bleeding time. Because they impair clot formation or promote clot lysis, they actually prolong bleeding and coagulation times significantly. Decreasing bleeding time would imply a procoagulant effect, which directly opposes the intended therapeutic mechanisms of these high-alert medications.
Test-taking strategy:
- Analyze the Classifications and Actions:
- Group the medications by their primary physiologic targets (platelets vs. clotting factors vs. existing fibrin).
- Differentiate between prophylactic mechanisms (preventing formation or extension) and rescue mechanisms (clot dissolution).
- Apply Pathophysiologic Principles:
- Recognize that fibrinolytics are the only class capable of active thrombolysis.
- Classify anticoagulants and platelet inhibitors as preventive agents that do not dissolve established structural fibrin.
- Eliminate Opposite Clinical Trends:
- Identify choice 4 ("decreases bleeding time") as an opposite effect.
- Rule out any matching for choice 4 because antithrombotics inherently increase systemic bleeding risk.
Take home points
- Fibrinolytic agents are the only drug class that actively dissolves an existing, fully formed fibrin thrombus.
- Anticoagulants and thrombin inhibitors prevent the growth and propagation of existing clots but do not degrade them.
- Platelet inhibitors target the primary hemostatic plug, whereas anticoagulants target the secondary coagulation cascade.
- All four drug classifications increase clinical bleeding risk and prolong standardized laboratory bleeding times.
The nurse is reviewing an order for alteplase, a fibrinolytic agent, to be administered for a hospitalized patient and recognizes that this drug can be used for which reasons? Select all that apply
The patient in the scenario with atrial fibrillation is started on warfarin; which laboratory tests will be monitored to determine the correct dosage? Select all that apply
The nurse initiates discharge teaching for the patient in the scenario who is being maintained on warfarin after hospitalization to prevent clot formation. Which statement by the patient indicates that further teaching is needed?
The nurse will monitor the therapeutic effect, as well as the adverse effects of anticoagulation therapy. Indicate with an “X” which assessment finding is part of the therapeutic effect and which is an adverse effect from anticoagulation therapy.
Explanation
Anticoagulation therapy requires balancing the prevention of thromboembolic complications with the serious risk of systemic hemorrhage. Therapeutic success is marked by stable hemodynamic parameters and appropriate prolongation of the coagulation profile. Conversely, toxic accumulation or overdosage manifests as active bleeding, occult blood in excretions, or hypovolemic shock.
Rationale for correct answers
B. Stable vital signs after taking these drugs for several months indicate that the patient is hemodynamically stable without suffering from occult bleeding. It demonstrates that long-term anticoagulation has not caused significant blood loss or disrupted cardiovascular homeostasis. This finding directly reflects a safe, therapeutic response to the prescribed medication regimen.
E. An International Normalized Ratio of 2.2 is within the established therapeutic range of 2.0 to 3.0 for standard warfarin anticoagulation. This level indicates adequate suppression of vitamin K-dependent clotting factors to prevent thrombosis while keeping the risk of major hemorrhage low. This value is a primary clinical indicator of therapeutic efficacy.
Rationale for incorrect answers
A. A positive guaiac stool test indicates the presence of microscopic, occult blood within the gastrointestinal tract. This finding is a pathological sign of mucosal injury and gastrointestinal bleeding secondary to drug-induced coagulation inhibition. It is a critical indicator of adverse drug effects rather than a desired therapeutic outcome.
C. Hematuria represents the pathological excretion of intact red blood cells in the urine due to renal or mucosal micro-hemorrhage. The nurse identifies this finding as a clear sign of localized bleeding caused by excessive anticoagulation. It represents a significant and dangerous adverse drug reaction requiring immediate clinical intervention.
D. Moist clammy skin accompanied by a weak rapid pulse are classic physiological signs of stage 2 or stage 3 hypovolemic shock. This state is triggered by rapid, severe internal hemorrhage that depletes the circulating blood volume and triggers compensatory sympathetic nervous activation. This represents a life-threatening adverse emergency.
Test-taking strategy
- Analyze the Scenario and Question: The patient is undergoing anticoagulation therapy. The nurse must classify five distinct assessment findings as either a desired therapeutic effect or an unwanted adverse effect.
- Apply Principles of Hemostasis and Coagulation: Group the findings by their physiological meaning to distinguish stable, therapeutic outcomes from hemorrhagic complications.
- Identify Indicators of Stability and Efficacy:
- Select stable vital signs (finding 2) because it shows a lack of active bleeding and preserved hemodynamics over months.
- Select an INR of 2.2 (finding 5) because it falls within the standard therapeutic range of 2.0 to 3.0, proving medication efficacy.
- Identify Indicators of Hemorrhagic Complications:
- Classify positive guaiac stool test (finding 1) and hematuria (finding 3) as adverse effects because they represent abnormal gastrointestinal and urinary bleeding.
- Classify moist clammy skin and a weak rapid pulse (finding 4) as adverse effects because they indicate cardiovascular decompensation due to severe hemorrhage.
- Identify Indicators of Stability and Efficacy:
Take home points
- Therapeutic anticoagulation is marked by stable hemodynamic parameters and a target INR range of 2.0 to 3.0.
- Occult gastrointestinal bleeding and macroscopic hematuria are common adverse effects indicating excessive anticoagulation.
- Hypovolemic shock presenting as cool, clammy skin and tachycardia is a life-threatening adverse reaction to bleeding.
- Monitoring programs must evaluate both laboratory coagulation assays and clinical signs of systemic perfusion to ensure safety.
A client with a congenital coagulation disorder is given aminocaproic acid (Amicar) to stop bleeding following surgery. The nurse will carefully monitor this client for development of which of the following adverse effects? Select all that apply
The nurse is monitoring a patient who is receiving antithrombolytic therapy in the emergency department because of a possible MI. Which adverse effect would be of the greatest concern at this time?
The nurse is assessing a patient who has a new prescription for vorapaxar (Zontivity). Which of these conditions are considered contraindications to the use of vorapaxar? Select all that apply
What’s the most common adverse reaction experienced with IV antiplatelet drugs?
A nurse is planning to administer subcutaneous enoxaparin (Lovenox) to an adult client following hip arthroplasty. Which of the following actions should the nurse plan to take?
A nurse is caring for a hospitalized client who is receiving IV heparin for a deep-vein thrombosis. The client begins vomiting blood. After the heparin has been stopped, which of the following medications should the nurse prepare to administer?
A nurse is planning to administer IV alteplase (Activase) to a client who is demonstrating manifestations of a massive pulmonary embolism. Which of the following interventions is appropriate for the nurse to plan?
A client with deep venous thrombosis (DVT) is receiving an infusion of heparin and will be started on warfarin (Coumadin) soon. While the client is receiving heparin, what laboratory test will provide the nurse with information about its therapeutic effects?
The client receiving heparin therapy asks how the “blood thinner” works. What is the best response by the nurse?
What client education should be included for a client receiving enoxaparin (Lovenox)? Select all that apply
A patient is placed on heparin, and the nurse acknowledges that heparin is effective for preventing clot formation in patients who have which disorder(s)? Select all that apply
A patient received a double dose of heparin during surgery and is bleeding through the incision site. While the surgeons are working to stop the bleeding at the incision site, the nurse will prepare to take what action?
A patient is being changed from an injectable anticoagulant to an oral anticoagulant. Which anticoagulant does the nurse realize is administered orally?
A patient is taking warfarin 5 mg/day for atrial fibrillation. The patient’s international normalized ratio (INR) is 3.8. The nurse would consider the INR to be what?
Sign Up or Login to view all the 20 Questions on this Exam
Join over 100,000+ nursing students using Naxlex’s science-backend flashcards, practice tests and expert solutions to improve their grades and reach their goals.
Sign Up Now
